Phase II, Randomized, Double-blind, Placebo-controlled Trial of the AOBO-001 for the Treatment of Overactive Bladder With Symptoms of Urge Urinary Incontinence and Frequency
Phase of Trial: Phase II
Latest Information Update: 15 Nov 2011
At a glance
- Drugs AOBO 001 (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 15 Nov 2011 Actual end date (1 Nov 2011) added as reported by ClinicalTrials.gov.
- 15 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.